Chemomab Therapeutics (CMMB) Net Income towards Common Stockholders (2017 - 2026)
Chemomab Therapeutics (CMMB) reported Net Income towards Common Stockholders of $2.17 million for Q2 2026, up 5.3% from $2.06 million a year earlier.
Powered by 
Analysis
Chemomab Therapeutics (CMMB) Net Income towards Common Stockholders (2017 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Chemomab Therapeutics' Net Income towards Common Stockholders came in at $4.01 million, down 22.6% year-over-year; for FY2025, it was $9 million, down 35.5% from FY2024.
- Net Income towards Common Stockholders has declined for three consecutive years.
- By year, Net Income towards Common Stockholders came in at $13.95 million in FY2024 (-42.4%), $24.22 million in FY2023 (-12.4%), $27.65 million in FY2022 (+121.6%) and $12.48 million in FY2021.
- The Q2 2026 figure ranks as the highest quarterly Net Income towards Common Stockholders since Q4 2024.
- Year over year, Net Income towards Common Stockholders gained in 1 of the last five quarters, with an average decline of 21.9%.
- The high point for year-over-year Net Income towards Common Stockholders in five years was Q2 2023 (growth of 28.8%); the low point was Q4 2023 (a decline of 58.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at -$1.77 million (Q1 2026), $1.87 million (Q4 2025) and $1.74 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.61 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -248.00 Mn |
| 10 | Chemomab Therapeutics | 10.28 Mn | 10.28 Mn | - | 2.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.17 Mn |
| Mar 31, 2026 | -1.77 Mn |
| Dec 31, 2025 | 1.87 Mn |
| Sep 30, 2025 | 1.74 Mn |
| Jun 30, 2025 | 2.06 Mn |
| Mar 31, 2025 | -3.32 Mn |
| Dec 31, 2024 | 2.96 Mn |
| Sep 30, 2024 | 3.48 Mn |
| Jun 30, 2024 | -3.63 Mn |
| Mar 31, 2024 | -3.87 Mn |
| Dec 31, 2023 | 3.42 Mn |
| Sep 30, 2023 | 4.08 Mn |
| Jun 30, 2023 | 7.97 Mn |
| Mar 31, 2023 | -8.75 Mn |
| Dec 31, 2022 | 8.27 Mn |
| Sep 30, 2022 | 8.08 Mn |
| Jun 30, 2022 | 6.19 Mn |
| Mar 31, 2022 | -5.10 Mn |
| Dec 31, 2021 | 19.92 Mn |
| Sep 30, 2021 | -2.97 Mn |
API Access
Chemomab Therapeutics Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=CMMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "CMMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=CMMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();